Transcript Daily logo

The Latest Headlines at Transcript Daily

Image about BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $102.00

BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $102.00

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target boosted by Wells Fargo & Company from $98.00 to $102.00 in a report issued on Tuesday morning,Benzinga reports. Wells Fargo & Company currently has an... More of this article »
Image about Alamar Biosciences (NASDAQ:ALMR) Price Target Raised to $35.00

Alamar Biosciences (NASDAQ:ALMR) Price Target Raised to $35.00

Alamar Biosciences (NASDAQ:ALMR – Free Report) had its price target raised by JPMorgan Chase & Co. from $32.00 to $35.00 in a research note published on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has an... More of this article »
Image about Rapid7 (NASDAQ:RPD) Price Target Raised to $12.00

Rapid7 (NASDAQ:RPD) Price Target Raised to $12.00

Rapid7 (NASDAQ:RPD – Free Report) had its price target upped by Stephens from $10.00 to $12.00 in a research note published on Tuesday,Benzinga reports. They currently have an equal weight rating on the technology company’s... More of this article »
Image about Oruka Therapeutics’ (ORKA) “Buy” Rating Reiterated at BTIG Research

Oruka Therapeutics’ (ORKA) “Buy” Rating Reiterated at BTIG Research

BTIG Research reaffirmed their buy rating on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report published on Tuesday morning,Benzinga reports. BTIG Research currently has a $151.00 target price on the stock. Other... More of this article »
Image about Wells Fargo & Company Cuts Optimum Communications (NYSE:OPTU) Price Target to $0.75

Wells Fargo & Company Cuts Optimum Communications (NYSE:OPTU) Price Target to $0.75

Optimum Communications (NYSE:OPTU – Free Report) had its target price lowered by Wells Fargo & Company from $1.00 to $0.75 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has an underweight... More of this article »
Image about MetLife (NYSE:MET) Price Target Raised to $108.00

MetLife (NYSE:MET) Price Target Raised to $108.00

MetLife (NYSE:MET – Free Report) had its price target increased by JPMorgan Chase & Co. from $106.00 to $108.00 in a research report sent to investors on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently... More of this article »
Image about JPMorgan Chase & Co. Cuts Zillow Group (NASDAQ:ZG) Price Target to $62.00

JPMorgan Chase & Co. Cuts Zillow Group (NASDAQ:ZG) Price Target to $62.00

Zillow Group (NASDAQ:ZG – Free Report) had its price target reduced by JPMorgan Chase & Co. from $76.00 to $62.00 in a research report released on Tuesday,Benzinga reports. They currently have an overweight rating on the... More of this article »
Image about BTIG Research Cuts Tactile Systems Technology (NASDAQ:TCMD) Price Target to $39.00

BTIG Research Cuts Tactile Systems Technology (NASDAQ:TCMD) Price Target to $39.00

Tactile Systems Technology (NASDAQ:TCMD – Free Report) had its price objective cut by BTIG Research from $40.00 to $39.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating... More of this article »
Image about Citigroup Cuts Zoetis (NYSE:ZTS) Price Target to $96.00

Citigroup Cuts Zoetis (NYSE:ZTS) Price Target to $96.00

Zoetis (NYSE:ZTS – Free Report) had its price objective cut by Citigroup from $112.00 to $96.00 in a research report sent to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock. A number of other... More of this article »
Image about Royal Bank Of Canada Cuts NuScale Power (NYSE:SMR) Price Target to $10.00

Royal Bank Of Canada Cuts NuScale Power (NYSE:SMR) Price Target to $10.00

NuScale Power (NYSE:SMR – Free Report) had its price target trimmed by Royal Bank Of Canada from $14.00 to $10.00 in a research report report published on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has... More of this article »
Image about Citigroup Cuts Amrize (NYSE:AMRZ) Price Target to $58.00

Citigroup Cuts Amrize (NYSE:AMRZ) Price Target to $58.00

Amrize (NYSE:AMRZ – Free Report) had its target price lowered by Citigroup from $66.00 to $58.00 in a research note published on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Other analysts... More of this article »
Image about Par Pacific (NYSE:PARR) Price Target Raised to $85.00

Par Pacific (NYSE:PARR) Price Target Raised to $85.00

Par Pacific (NYSE:PARR – Free Report) had its price objective hoisted by Mizuho from $80.00 to $85.00 in a report published on Tuesday morning, MarketBeat reports. The firm currently has an outperform rating on the stock. PARR... More of this article »
Image about Hims & Hers Health (NYSE:HIMS) Price Target Raised to $42.00

Hims & Hers Health (NYSE:HIMS) Price Target Raised to $42.00

Hims & Hers Health (NYSE:HIMS – Free Report) had its target price lifted by Needham & Company LLC from $35.00 to $42.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating... More of this article »
Image about Quantum Computing’s (QUBT) Neutral Rating Reiterated at Cantor Fitzgerald

Quantum Computing’s (QUBT) Neutral Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reiterated their neutral rating on shares of Quantum Computing (NASDAQ:QUBT – Free Report) in a report released on Tuesday, MarketBeat.com reports. They currently have a $10.00 price objective on the stock. Several... More of this article »
Image about Cardinal Health (NYSE:CAH) Reaches New 1-Year High After Better-Than-Expected Earnings

Cardinal Health (NYSE:CAH) Reaches New 1-Year High After Better-Than-Expected Earnings

Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) reached a new 52-week high during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $258.30 and last traded at $240.0820,... More of this article »